Overview

Scars After Central Venous Catheters

Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
0
Participant gender:
All
Summary
Most children with cancer need a central venous catheter. These catheters are typically placed on the anterior thorax, where the risk of hypertrophic scarring and keloid development is greatly enhanced. A significant part of the children who have survived childhood cancer are troubled by their scars. Topical glucocorticoid treatment is known to induce a reduction of the collagen in the connective tissue. The investigators hypothesize that treatment with topical glucocorticoids for one week before and three weeks after removal of a central venous catheter, will reduce the formation of hypertrophic scarring and keloid development in children.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mette Møller Handrup
Treatments:
Fusidic Acid
Criteria
Inclusion Criteria:

- All children and adolescents who have a central venous catheter removed at the
Childrens Department of Oncology at Aarhus University Hospital Skejby in the period
from March 2010 to July 2011

Exclusion Criteria:

- Known allergy towards plaster or fusidic acid